Atlas FDA

Edwards EVOQUE Tricuspid Valve Replacement System

FDA premarket approval P230013/S004 · decided 2024-10-03

Approval details

PMA number
P230013
Supplement
S004
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Edwards EVOQUE Tricuspid Valve Replacement System
Generic name
Percutaneously Delivered Prostheses and Tricuspid Valves
Applicant
Edwards Lifesciences, LLC
Date received
2024-04-25
Decision date
2024-10-03
Days to decision
161 days
Decision code
APPR
Product code
NPW
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval for (1) addition of the 56 mm valve size; (2) various minor material and manufacturing changes to all valve sizes, including changing the anchor padding material and laser-cutting of the cloth components; and (3) various design changes to the EVOQUE loading system (Model 9850LSA).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02